A Study to Determine the Relative Oral Bioavailability of Single Dose Administration of TMC207, Under Fed and Fasted Conditions in Healthy Participants

NCT00946842 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Treatment A
DRUG: Treatment B
DRUG: Treatment C
DRUG: Treatment D
DRUG: Treatment E
DRUG: Treatment F

Sponsor

Tibotec BVBA